(Q86044365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

main subject

neoadjuvant chemotherapy

1 reference

Michael J Worley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Stephanie H Guseh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J Alejandro Rauh-Hain

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Kristina A Williams

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Michael G Muto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Colleen M Feltmate

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Ross S Berkowitz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Neil S Horowitz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

31 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

69-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Ovarian cancer. Survival and treatment differences by age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Contemporary considerations for neoadjuvant chemotherapy in primary ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Morbidity of cytoreductive surgery in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Rehospitalizations among patients in the Medicare fee-for-service program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Developing strategies for predicting and preventing readmissions in vascular surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Ovarian cancer in the elderly patient: are we doing enough?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Predictors and outcome of readmission after laparoscopic intestinal surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Multivariable analysis of factors associated with hospital readmission after intestinal surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.012

10.1016/J.YGYNO.2013.01.012

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375727%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference